Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Medication Guide

Trazodone

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference partial Not FDA-approved for animals Multiple FDA labelers Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Aug 6, 2026, 7:47 p.m.

Roxee has a partial reference profile for this medication. Some primary facts still need verification.

FDA applications
FDA application data refreshed
Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Trazodone

Trazodone

Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals

Both 81% reference complete

Species: Both

Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Trazodone

Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus. Species commonly shown: Both.

Generic name
Trazodone
Brand names
Trazodone HCl
Manufacturer
Multiple FDA labelers
Species
Both
Completeness
81%
Validation
Incomplete
Brand names
Trazodone HCl

Indications / Uses

Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus.

Side Effects

Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in Neurological), Decreased appetite, Death by euthanasia, Not eating.

FAQ

Both

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Roxee still has limited plain-language guidance for this medication. Use the official documents and your veterinarian's instructions for product-specific details.

Used for:

Your vet decides this. Here's what owners typically ask/watch for.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Hair loss (1 reports)
  • Cyst NOS (1 reports)
  • Cyanotic mucous membranes (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence
Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Trazodone; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2026-US-011403
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 26 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2026-US-011403
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2026-US-011403
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Hair loss (1 reports), Cyst NOS (1 reports), Cyanotic mucous membranes (1 reports), Crust (1 reports), Convulsion (1 reports)

Body systems represented Signal grouping

Digestive (1), Skin & allergy (2), Neurologic (3), Behavior (2)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (28 reports), Cat (4 reports)

Breed metadata in reports Metadata only

Crossbred Canine/dog (2), Dachshund - Miniature (1), Dog (unknown) (1), Retriever - Labrador (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Trazodone fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Hair loss, Cyst NOS, Cyanotic mucous membranes

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Trazodone brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2026-US-011403 · adverse_reaction · adverse reactions
  2. Structured Product Label · document · documents
  3. Structured Product Label · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Hair loss
  • Cyst NOS
  • Cyanotic mucous membranes

Most reported reactions:

  • Hair loss (1 reports)
  • Cyst NOS (1 reports)
  • Cyanotic mucous membranes (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Not linked yet
Indication / use
Your vet decides this. Here's what owners typically ask/watch for.
Form / route / dose
Confirm product label and patient-specific plan.
Warnings
No structured warnings linked yet.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Identifiers:
NDC Package: 73309-317-01 NDC Package: 73309-317-02 NDC Package: 73377-170-01 NDC Package: 73377-170-02 NDC Product: 73309 NDC Product: 73377

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
21
Matching reports
1
Active filters
2
Selected filters
Reaction: Decreased appetite Clear Body system: Neurologic Clear
Reset
Drill into common report signals
Lethargy (see also Central nervous system depression in Neurological) (4) Abnormal radiograph finding (2) Confusion (2) Decreased appetite (2) Other (19) Neurologic (8) Digestive (7) Effectiveness (4)
Showing up to 50 matching reports.

USA-USFDACVM-2026-US-014559

Received 2026-03-17 · MSK · MSK

Serious
Species
Dog
Breed
Crossbred Canine/dog
Size / weight
50-99 lb (37.648 Kilogram)
Age
4-7 years (7 Year)
Sex
Male Neutered
Region
USA
Reactions
RegurgitationMalaiseWobblinessBalance problemWeaknessConfusionCircling - neurological disorder (see also Behavioural disorders)VomitingDecreased appetiteDecreased bowel movementsLeukocytosis NOSNeutrophiliaMonocytosisEosinopeniaHypoproteinaemiaReduced globulinsElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)
Body systems
OtherNeurologicDigestive
Outcomes
Ongoing

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
26
Species represented
2
Grouped by Body System
Digestive (1) · Bloody diarrhoea Skin & allergy (2) · Hair loss, Alopecia general Neurologic (3) · Unsteady walking (ataxia), Convulsion, Circling - neurological disorder Behavior (2) · Behavioral disorder (unspecified), Anxiety Other (24) · Cyst NOS, Cyanotic mucous membranes, Crust
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Skin & allergy 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Neurologic 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (28) Cat (4)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Cat Non-serious - 1
Skin & allergy Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Neurologic Dog Serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Neurologic Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Digestive Dog Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Behavior Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Skin & allergy Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Source metadata:

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Trazodone HCl SPL SPL · Structured Product Label Trazodone HCl SPL SPL · Structured Product Label

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

2

FOI

0
No FOI links yet.

Trazodone HCl SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Trazodone HCl. Use the source link for the full official labeling record.

Trazodone HCl SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Trazodone HCl. Use the source link for the full official labeling record.
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Trazodone HCl
Manufacturer mapping: Multiple FDA labelers
Case-reported brands (openFDA): MSK
Catalog species: Both
NDC: Packages 73309-317-01 73309-317-02 73377-170-01 73377-170-02 • Products 73309 73377
Safety (openFDA)
Top reactions: Dog 107 • Cat 3 • View
Case summaries: 21 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Top reaction signals
Hair loss (1) Cyst NOS (1) Cyanotic mucous membranes (1) Crust (1) Convulsion (1) Confusion (1) Coma (1) Collapse NOS (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NDC Package: 73309-317-01 NDC Package: 73309-317-02 NDC Package: 73377-170-01 NDC Package: 73377-170-02 NDC Product: 73309 NDC Product: 73377
Package NDC Product NDC Form / Route Status
73309-317-01 73309 -
73309-317-02 73309 -
73377-170-01 73377 -
73377-170-02 73377 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • Trazodone HCl SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Trazodone HCl SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 115 Clinical 7 Manufacturer 0 Marketing 0
Current Field Facts
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in Neurological), Decreased appetite, Death by euth… (Clinical, 2026-04-11)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-08-06)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-08-05)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-08-04)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-08-03)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-08-02)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-08-01)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-31)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-30)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-29)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-28)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-27)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-26)
  • manufacturer_name: Multiple FDA labelers (Official, 2026-07-25)
Recent Revisions
  • side_effects updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-13 10:06 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-12 17:56 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-11 19:04 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-11 08:49 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-11 08:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-10 21:24 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-07 10:06 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-06 20:16 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-06 08:13 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-03 20:16 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-03 11:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-02 22:45 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-07-01 23:29 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published

Data source: FDA Animal Drugs @ FDA (public search export).

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Bloody diarrhoea (1) • Dog

Showing top 5 for Digestive.

Skin & allergy
Hair loss (1) • Cat Alopecia general (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Cat Convulsion (1) • Dog Circling - neurological disorder (1) • Dog

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Dog Anxiety (1) • Dog

Showing top 5 for Behavior.

Other
Cyst NOS (1) • Dog Cyanotic mucous membranes (1) • Dog Crust (1) • Dog Constricted pupils (1) • Cat Confusion (1) • Dog
Show more (19)
Coma (1) • Dog Collapse NOS (1) • Dog Colitis (1) • Dog Cellulitis (1) • Dog Cardiorespiratory arrest (1) • Dog Bumps on skin (1) • Dog Bradycardia (1) • Dog Balance problem (1) • Dog Asystole (1) • Dog Aspiration pneumonia (1) • Cat Application site serous discharge (1) • Dog Anal and rectal disorder NOS (1) • Dog Anaemia NOS (1) • Dog Allergy NOS (1) • Dog Agitation (1) • Dog Abnormal radiograph finding (1) • Dog Abnormal menace reflex test (1) • Dog Abnormal cytology (1) • Dog Abdominal discomfort (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Dachshund - Miniature, Male, 9 month, 3.2 kilogram • Drug: MSK, Oral • Reactions: Vomiting • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2026-US-014631
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 9.00 Month
  • Weight: 3.200 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
Reactions Reported:
Vomiting
Outcomes: Recovered/Normal

Dog, Dog (unknown), Male, 9 year • Drug: MSK, Tablet, Oral, Dose: 50 Milligram per animal • Reactions: Nausea, Indigestion • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-025912
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 9.00 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Tablet
  • Dose: 50 Milligram per animal
Reactions Reported:
Nausea Indigestion
Outcomes: Outcome Unknown

Dog, Retriever - Labrador, Female, 8 year, 42.8 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy - NOS • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2026-US-013334
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 8.00 Year
  • Weight: 42.800 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Lack of efficacy - NOS
Outcomes: Outcome Unknown

Dog, Shepherd Dog - German, Female, 4 year, 30.844 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Injection site pain, Injection site swelling, Vomiting, Decreased appetite, Pica NOS… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-012895
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 4.00 Year
  • Weight: 30.844 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Injection site pain Injection site swelling Vomiting Decreased appetite Pica NOS Localised pain NOS Eosinophilia
Outcomes: Ongoing

Dog, Crossbred Canine/dog, Male, 7 year, 37.648 kilogram • Drug: MSK, Tablet, Oral • Reactions: Regurgitation, Malaise, Wobbliness, Balance problem, Weakness… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014559
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 7.00 Year
  • Weight: 37.648 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Tablet
Reactions Reported:
Regurgitation Malaise Wobbliness Balance problem Weakness Confusion Circling - neurological disorder Vomiting Decreased appetite Decreased bowel movements Leukocytosis NOS Neutrophilia Monocytosis Eosinopenia Hypoproteinaemia Reduced globulins Elevated alanine aminotransferase Elevated serum alkaline phosphatase
Outcomes: Ongoing

Dog, Corso Dog, Female, 1 year, 42.184 kilogram • Drug: MSK, Unknown • Reactions: Tiredness (lethargy), Not eating, Fever, Injection site lump, Application site serous discharge • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013265
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 1.00 Year
  • Weight: 42.184 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Tiredness (lethargy) Not eating Fever Injection site lump Application site serous discharge
Outcomes: Ongoing

Dog, Crossbred Canine/dog, Female, 10 year, 15.876 kilogram • Drug: MSK, Unknown • Reactions: Itching, Licking • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013584
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 10.00 Year
  • Weight: 15.876 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Itching Licking
Outcomes: Ongoing

Dog, ['Beagle', 'Dog (unknown)'], Female, 8 year, 22.044 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - roundworm NOS, Lack of efficacy (endoparasite) - hookworm, Excessive appetite, Anal and rectal disorder NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013526
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 8.00 Year
  • Weight: 22.044 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Lack of efficacy (endoparasite) - roundworm NOS Lack of efficacy (endoparasite) - hookworm Excessive appetite Anal and rectal disorder NOS
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.